Rapport Therapeutics, Inc. (NASDAQ:RAPP) IPO
IPO
Priced at US$17.00 a share on Jun 6, 2024.
- Price
- US$17.00 a share
- Shares offered
- 8,000,000 shares of common stock
- Offering size
- US$136 million
- Underwriters' option
- Up to 1,200,000 more shares
- Underwriters
- Goldman Sachs & Co. LLC, Jefferies, TD Cowen, Stifel · In the order on the cover
- Shares delivered
- On or about Jun 10, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Mar 27, 2024 |
| Filed publicly | May 17, 2024 |
| Amended once | Jun 3, 2024 |
| Shares registered with an exchange | Jun 4, 2024 |
| Declared effective by the SEC | Jun 6, 2024 |
| Final prospectus, with the price | Jun 7, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 7, 2024 |
| EFFECT · Notice that a registration is effective | Jun 6, 2024 |
| CERT · Exchange's certificate of listing | Jun 6, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 4, 2024 |
| CORRESP · Letter to the SEC | Jun 4, 2024 |
| CORRESP · Letter to the SEC | Jun 4, 2024 |
| CORRESP · Letter to the SEC | Jun 3, 2024 |
| S-1/A · Registration statement, amended | Jun 3, 2024 |
| CORRESP · Letter to the SEC | May 29, 2024 |
| UPLOAD · Letter from the SEC | May 24, 2024 |
| CORRESP · Letter to the SEC | May 17, 2024 |
| S-1 · Registration statement | May 17, 2024 |
| UPLOAD · Letter from the SEC | May 13, 2024 |
| DRSLTR · Letter to the SEC with a draft | Apr 29, 2024 |
| DRS/A · Draft registration statement, amended | Apr 29, 2024 |
| UPLOAD · Letter from the SEC | Apr 24, 2024 |
| DRS · Draft registration statement | Mar 27, 2024 |
From the cover of the final prospectus (424B4) filed Jun 7, 2024